CVS Health: A Value Investor’s Autopsy of a Healthcare Giant Under PressureRead More »
This content is restricted to site members. If you are an existing user, please log in. New users may register below.
CVS Health: A Value Investor’s Autopsy of a Healthcare Giant Under Pressure
Views: 181 2026-02-10 CVS Health is an integrated healthcare conglomerate combining retail pharmacy, pharmacy benefit management, health insurance, and healthcare services. It generates revenue primarily through prescription dispensing, insurance premiums, PBM administration fees, and clinical services delivered via MinuteClinic and Oak Street Health. Scale is its defining feature, with nearly $400 billion in annual revenue and deep integration across the healthcare value chain. However, profitability is thin, capital intensity is high, and returns on invested capital remain below the cost of capital. CVS is a systemically important operator, but one currently struggling to convert scale into durable shareholder value. Investment …
